Govind Tekale
Texas carried out the execution of Jamaal Howard at the Huntsville Unit on October 7, 2026. Howard, 46, was pronounced dead at 8:03 PM CDT. The execution was the first in the United States since Tennessee's widely reported failed lethal injection attempt the previous week.
State officials reported no procedural complications.
The Case and the Protocol
Howard was convicted of the fatal 2000 shooting of Vickie Swartout, 42, in Hardin County, Texas. He had been on death row for more than two decades. The US Supreme Court denied his final appeals earlier in the week, rejecting arguments that he met the intellectual disability standard under Atkins v. Virginia.
Texas used a single five-gram lethal dose of pentobarbital, a potent barbiturate. The state's single-drug protocol differs from the three-drug sequences used in Oklahoma and Tennessee that have been associated with recent complications. Texas sources pentobarbital from undisclosed compounding pharmacies under state secrecy statutes that conceal supplier identities, batch testing records, and expiration information from judicial review.
The execution of Jamaal Howard shows that Texas remains committed to its single-drug lethal injection protocol despite mounting national scrutiny over chemical availability and medical ethics. Howard's rejected intellectual disability claim and the secrecy surrounding compounding sources deepen a legal divide between state execution efficiency and constitutional protections against cruel and unusual punishment that federal courts have not yet resolved.
What Sets This Execution Apart
Howard's case involved two issues that received limited coverage.
First, his disability claim: Howard's legal team argued he met the intellectual disability standard established in Atkins v. Virginia (2002), which exempts individuals with intellectual disability from capital punishment under the Eighth Amendment. Texas courts and ultimately the US Supreme Court rejected those arguments. Under Texas law, the intellectual disability threshold is defined by a narrow set of clinical criteria, and Howard's claims did not satisfy that standard.
Second, the drug supply question: Howard's appellate counsel filed an emergency motion claiming that Texas's current pentobarbital batch had exceeded its manufacturer's standard beyond-use date and was re-tested under state secrecy exemptions. The Fifth Circuit Court of Appeals ruled that procedural timeliness bars — deadlines for raising evidentiary challenges — blocked the chemical degradation argument from proceeding. The execution went forward.
That ruling illustrates a structural feature of Texas executions: the state's pharmacy secrecy statutes function as a legal shield against clinical oversight. Courts have repeatedly held that procedural timing rules take precedence over late-filed challenges to drug quality, even where independent verification is impossible by design.
Medical ethicists and board-certified anesthesiologists have submitted expert declarations in Eighth Amendment challenges across multiple states, citing evidence that pentobarbital at high doses can cause chemical pulmonary edema — fluid buildup in the lungs. Those declarations have not prevailed in Texas courts.
What drug does Texas use for lethal injections?
Texas carries out executions using a single five-gram dose of pentobarbital, sourced from undisclosed compounding pharmacies under state secrecy laws that conceal supplier identities and testing records. This differs from three-drug protocols used in other states — which include paralytics such as rocuronium bromide — that have been associated with recent execution failures.
Autopsy toxicology results in the Howard case would confirm or contradict the pulmonary edema concerns raised by medical experts. Federal courts are expected to continue evaluating state pharmacy secrecy statutes as compounded drug batches age beyond standard manufacturer timelines.
